share_log

Protagenic Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(5.26%),Steven Boyd(5.26%)

Protagenic Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Armistice Capital, LLC(5.26%),Steven Boyd(5.26%)

美股SEC公告 ·  2023/02/15 02:17
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息